Medicus Pharma Stock Short Ratio
| MDCX Stock | 3.95 0.25 6.76% |
Medicus Pharma fundamentals help investors to digest information that contributes to Medicus Pharma's financial success or failures. It also enables traders to predict the movement of Medicus Stock. The fundamental analysis module provides a way to measure Medicus Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicus Pharma stock.
Medicus |
Medicus Pharma Company Short Ratio Analysis
Medicus Pharma's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Medicus Pharma Short Ratio | 0.96 X |
Most of Medicus Pharma's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicus Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Medicus Pharma has a Short Ratio of 0.96 times. This is much higher than that of the sector and significantly higher than that of the Short Ratio industry. The short ratio for all Canada stocks is notably lower than that of the firm.
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
Medicus Fundamentals
| Current Valuation | 39.63 M | |||
| Shares Outstanding | 11.82 M | |||
| Number Of Shares Shorted | 900 | |||
| Price To Book | 9.40 X | |||
| Net Income | (6.78 M) | |||
| Total Debt | 1.09 M | |||
| Cash Flow From Operations | (4.16 M) | |||
| Short Ratio | 0.96 X | |||
| Earnings Per Share | (1.25) X | |||
| Target Price | 5.61 | |||
| Market Capitalization | 46.68 M | |||
| Total Asset | 1.89 M | |||
| Retained Earnings | (19.18 M) | |||
| Working Capital | 805.8 K | |||
| Net Asset | 1.89 M |
About Medicus Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicus Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicus Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicus Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medicus Stock Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.